- Home
- STKL vs IMTX Comparison
STKL vs IMTX Comparison
Compare STKL & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STKL
- IMTX
- Stock Information
- Founded
- STKL 1973
- IMTX N/A
- Country
- STKL United States
- IMTX Germany
- Employees
- STKL N/A
- IMTX N/A
- Industry
- STKL Precious Metals
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STKL Basic Materials
- IMTX Health Care
- Exchange
- STKL Nasdaq
- IMTX Nasdaq
- Market Cap
- STKL 730.4M
- IMTX 865.5M
- IPO Year
- STKL N/A
- IMTX N/A
- Fundamental
- Price
- STKL $5.91
- IMTX $9.39
- Analyst Decision
- STKL Strong Buy
- IMTX Strong Buy
- Analyst Count
- STKL 2
- IMTX 5
- Target Price
- STKL $9.50
- IMTX $15.00
- AVG Volume (30 Days)
- STKL 417.5K
- IMTX 800.4K
- Earning Date
- STKL 11-04-2025
- IMTX 11-17-2025
- Dividend Yield
- STKL N/A
- IMTX N/A
- EPS Growth
- STKL N/A
- IMTX N/A
- EPS
- STKL N/A
- IMTX N/A
- Revenue
- STKL $762,882,000.00
- IMTX $152,823,253.00
- Revenue This Year
- STKL $12.80
- IMTX N/A
- Revenue Next Year
- STKL $7.91
- IMTX N/A
- P/E Ratio
- STKL N/A
- IMTX N/A
- Revenue Growth
- STKL 11.44
- IMTX 83.61
- 52 Week Low
- STKL $3.65
- IMTX $3.30
- 52 Week High
- STKL $8.11
- IMTX $11.40
- Technical
- Relative Strength Index (RSI)
- STKL 42.46
- IMTX 79.00
- Support Level
- STKL $5.74
- IMTX $6.90
- Resistance Level
- STKL $6.15
- IMTX $9.25
- Average True Range (ATR)
- STKL 0.18
- IMTX 0.46
- MACD
- STKL -0.02
- IMTX 0.27
- Stochastic Oscillator
- STKL 22.08
- IMTX 95.86
About STKL SunOpta Inc.
SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.